Drugs / Exenatide ER
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02020616 | Dec 2013 → Feb 2015 | type 2 diabetes mellitus | Eli Lilly and Company | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Exenatide ER | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02020616 ↗ |
| Route | Subcutaneous | “Administered SC” NCT02020616 ↗ |